PATENT CLAIM ANALYSIS

Application Number: 15972943
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["424", "468000"]

Abstract:
A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.

Claim (Index 11):
The controlled release oral dosage form of  claim 1 , wherein the high molecular weight binder is HPMC, wherein the HPMC has a methoxyl content of about 19-24% and a hydroxypropyl content of about 7-12%, wherein the HPMC has a number average weight equal to or greater than about 80,000 daltons, and wherein the HPMC has an apparent viscosity of about 80,000-120,000 cps in a 2% solution of water at about 20\u00b0 C.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15621298', '12499034', '12378586', '12914054', '10569862']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7602922036406365
- 35 USC 102 Novelty (BERT): 0.5840149229651919
- Combined Prediction Score: 0.742664475573092
- Mean Citation Score: 294.003498
- Max Citation Score: 471.50354
- Similarity Product: 468.6548544180167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test